P203 CEEFAX 203  Thu  4 Nov  21:13/05
     
      WRITE-OFF HITS       
      BOOTS' FIGURES       
 
  Weighing on six-month figures from  
  Boots was a £35m write-off against  
  its Manoplax heart drug.            
                                      
  -hj company withdrew Manoplax in    
  July after tests revealed problems  
  associated with large doses.        
                                      
  Boots' last patented drug to go on  
  the market, it had cost the compan9 
  around £120m in development costs.  
                                      
  An interim profit of £199.8m before 
  exceptionals fell just shout of     
  most City expectations, as did the  
  4.9p dividend. A dividend of 5p had 
  been generally expected.            
 
   Headlines 201           Results 216  
 Next News ResultA-J Exchanges Mon yfile